These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 26889816)
1. MiR-155 expression level changes might be associated with initial phases of breast cancer pathogenesis and lymph-node metastasis. Petrović N; Kolaković A; Stanković A; Lukić S; Řami A; Ivković M; Mandušić V Cancer Biomark; 2016; 16(3):385-94. PubMed ID: 26889816 [TBL] [Abstract][Full Text] [Related]
2. Decreased expression of MicroRNA-200 family in human breast cancer is associated with lymph node metastasis. Xu F; He H; Huang W; Lin Y; Luo S; Du Q; Duan R Clin Transl Oncol; 2016 Mar; 18(3):283-8. PubMed ID: 26201425 [TBL] [Abstract][Full Text] [Related]
3. Role of miR-139 as a surrogate marker for tumor aggression in breast cancer. Dai H; Gallagher D; Schmitt S; Pessetto ZY; Fan F; Godwin AK; Tawfik O Hum Pathol; 2017 Mar; 61():68-77. PubMed ID: 27864119 [TBL] [Abstract][Full Text] [Related]
4. Expression and Tissue Distribution of MicroRNA-21 in Malignant and Benign Breast Tissues>. Hug KA; Anthony L; Eldeiry D; Benson J; Wheeler E; Mousa S; Shi B Anticancer Res; 2015 Jun; 35(6):3175-83. PubMed ID: 26026077 [TBL] [Abstract][Full Text] [Related]
5. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features. Wang B; Li J; Sun M; Sun L; Zhang X IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313 [TBL] [Abstract][Full Text] [Related]
6. The difference in miR-21 expression levels between invasive and non-invasive breast cancers emphasizes its role in breast cancer invasion. Petrović N; Mandušić V; Stanojević B; Lukić S; Todorović L; Roganović J; Dimitrijević B Med Oncol; 2014 Mar; 31(3):867. PubMed ID: 24488617 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of miR-21 expression in breast cancer: SYBR-Green I-based real-time RT-PCR study of invasive ductal carcinoma. Huang GL; Zhang XH; Guo GL; Huang KT; Yang KY; Shen X; You J; Hu XQ Oncol Rep; 2009 Mar; 21(3):673-9. PubMed ID: 19212625 [TBL] [Abstract][Full Text] [Related]
8. miR-21: A gene of dual regulation in breast cancer. Zhang C; Liu K; Li T; Fang J; Ding Y; Sun L; Tu T; Jiang X; Du S; Hu J; Zhu W; Chen H; Sun X Int J Oncol; 2016 Jan; 48(1):161-72. PubMed ID: 26549725 [TBL] [Abstract][Full Text] [Related]
9. Changes in miR-221/222 Levels in Invasive and In Situ Carcinomas of the Breast: Differences in Association with Estrogen Receptor and TIMP3 Expression Levels. Petrovic N; Davidovic R; Jovanovic-Cupic S; Krajnovic M; Lukic S; Petrovic M; Roganovic J Mol Diagn Ther; 2016 Dec; 20(6):603-615. PubMed ID: 27488105 [TBL] [Abstract][Full Text] [Related]
10. [Expression of microRNA-21 in invasive ductal carcinoma of the breast and its association with phosphatase and tensin homolog deleted from chromosome expression and clinicopathologic features]. Huang GL; Zhang XH; Guo GL; Huang KT; Yang KY; Hu XQ Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(40):2833-7. PubMed ID: 19080492 [TBL] [Abstract][Full Text] [Related]
11. TIMP-3 mRNA expression levels positively correlates with levels of miR-21 in in situ BC and negatively in PR positive invasive BC. Petrovic N; Sami A; Martinovic J; Zaric M; Nakashidze I; Lukic S; Jovanovic-Cupic S Pathol Res Pract; 2017 Oct; 213(10):1264-1270. PubMed ID: 28935174 [TBL] [Abstract][Full Text] [Related]
12. The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: potential biomarkers. Chen W; Cai F; Zhang B; Barekati Z; Zhong XY Tumour Biol; 2013 Feb; 34(1):455-62. PubMed ID: 23238818 [TBL] [Abstract][Full Text] [Related]
13. Targeting of CCBE1 by miR-330-3p in human breast cancer promotes metastasis. Mesci A; Huang X; Taeb S; Jahangiri S; Kim Y; Fokas E; Bruce J; Leong HS; Liu SK Br J Cancer; 2017 May; 116(10):1350-1357. PubMed ID: 28419078 [TBL] [Abstract][Full Text] [Related]
14. Abnormal expression of miR-1 in breast carcinoma as a potent prognostic factor. Minemura H; Takagi K; Miki Y; Shibahara Y; Nakagawa S; Ebata A; Watanabe M; Ishida T; Sasano H; Suzuki T Cancer Sci; 2015 Nov; 106(11):1642-50. PubMed ID: 26331797 [TBL] [Abstract][Full Text] [Related]
15. The clinico-pathologic role of microRNAs miR-9 and miR-151-5p in breast cancer metastasis. Krell J; Frampton AE; Jacob J; Pellegrino L; Roca-Alonso L; Zeloof D; Alifrangis C; Lewis JS; Jiao LR; Stebbing J; Castellano L Mol Diagn Ther; 2012 Jun; 16(3):167-72. PubMed ID: 22489664 [TBL] [Abstract][Full Text] [Related]
16. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer. Dong LL; Chen LM; Wang WM; Zhang LM Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779 [TBL] [Abstract][Full Text] [Related]
17. Lower expression of miR-218 in human breast cancer is associated with lymph node metastases, higher grades, and poorer prognosis. Ahmadinejad F; Mowla SJ; Honardoost MA; Arjenaki MG; Moazeni-Bistgani M; Kheiri S; Teimori H Tumour Biol; 2017 Aug; 39(8):1010428317698362. PubMed ID: 28857013 [TBL] [Abstract][Full Text] [Related]
18. PDIA3 and PDIA6 gene expression as an aggressiveness marker in primary ductal breast cancer. Ramos FS; Serino LT; Carvalho CM; Lima RS; Urban CA; Cavalli IJ; Ribeiro EM Genet Mol Res; 2015 Jun; 14(2):6960-7. PubMed ID: 26125904 [TBL] [Abstract][Full Text] [Related]
19. miR-21 Might be Involved in Breast Cancer Promotion and Invasion Rather than in Initial Events of Breast Cancer Development. Petrović N Mol Diagn Ther; 2016 Apr; 20(2):97-110. PubMed ID: 26891730 [TBL] [Abstract][Full Text] [Related]
20. Prognostic and biological significance of microRNA-127 expression in human breast cancer. Wang S; Li H; Wang J; Wang D; Yao A; Li Q Dis Markers; 2014; 2014():401986. PubMed ID: 25477702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]